Category 3: Tactical Day-to-Day Nutrition & Safety · Episode 22

GLP-1 & Birth Control Pills: What Doctors Don't Tell You

Clinical Answer Capsule: GLP-1 receptor agonist-induced delayed gastric emptying significantly alters the pharmacokinetic absorption profile of oral hormonal contraceptive pills, lowering peak plasma concentrations below protective thresholds. The FDA advises that patients utilizing oral birth control pills switch to non-oral contraceptive methods (such as IUDs, subdermal implants, or barrier protection) during dose escalation.
Delayed Gastric Absorption KineticsOral Contraceptive Efficacy ReductionIncretin PharmacokineticsNon-Oral Barrier ProtectionFDA Reproductive Drug Safety
Executive Action Script
"Delayed gastric emptying slows oral contraceptive absorption below clinical efficacy thresholds. Non-oral contraception (IUD, patch, barrier) is medically indicated."

Full Video Dialogue & Clinical Context

Did your doctor warn you about 'Ozempic babies'? Because if you take oral birth control pills while on a GLP-1, you are at serious risk of unplanned pregnancy. GLP-1s dramatically delay gastric emptying, meaning your oral contraceptive pill sits in your stomach and fails to absorb into your bloodstream at the critical hormonal window. Switch to an IUD, implant, or non-oral barrier method, especially during dose increases. Protect yourself. Grab the Medication Safety Screener at bitchesandbesties.com/armory.

🔬 Verified Clinical Reference:
FDA Drug Safety Communication: Pharmacokinetic impact of delayed gastric emptying on oral hormonal contraceptives during incretin titration. PMID: 32018898
Access Study: https://pubmed.ncbi.nlm.nih.gov/32018898/
Featured Armory Instrument
Tool 03: The Telehealth & Compounding Safety Screener
Includes clinical drug interaction audits and reproductive safety guidelines for incretin patients.
Unlock Free Instrument in The Armory →